 
                        | Product NDC: | 0378-1903 | 
| Proprietary Name: | Midodrine Hydrochloride | 
| Non Proprietary Name: | midodrine hydrochloride | 
| Active Ingredient(s): | 10 mg/1 & nbsp; midodrine hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0378-1903 | 
| Labeler Name: | Mylan Pharmaceuticals Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA076577 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20120507 | 
| Package NDC: | 0378-1903-01 | 
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0378-1903-01) | 
| NDC Code | 0378-1903-01 | 
| Proprietary Name | Midodrine Hydrochloride | 
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0378-1903-01) | 
| Product NDC | 0378-1903 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | midodrine hydrochloride | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20120507 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Mylan Pharmaceuticals Inc. | 
| Substance Name | MIDODRINE HYDROCHLORIDE | 
| Strength Number | 10 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |